查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1987367

醫用迴旋加速器市場規模、佔有率、趨勢和預測：按類型、產品類型、最終用戶和地區分類，2026-2034年

Medical Cyclotron Market Size, Share, Trends and Forecast by Type, Product Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球醫用迴旋加速器市場規模為2.654億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到4.938億美元，2026年至2034年的複合年成長率（CAGR）為6.93%。 2025年，亞太地區引領市場。推動醫用迴旋加速器市場佔有率成長的關鍵因素包括癌症發病率上升、放射性藥物技術的進步、正電子發射斷層掃描（PET）需求的成長、技術創新、醫療基礎設施的擴建、研究活動的活性化以及政府對核醫學和診斷成像的支持。

由於幾個關鍵因素，市場正穩步成長。其中一個主要促進因素是對影像檢查（尤其是正子斷層掃描 (PET)）的需求不斷成長，而PET檢查需要使用迴旋加速器生產的放射性同位素。全球癌症和心血管疾病發生率的上升進一步增加了對早期、精準診斷工具的需求。放射性藥物和影像技術的進步提高了診斷的效率和準確性，從而促進了迴旋加速器系統部署的擴展。此外，新興國家醫療基礎設施的擴張和對核子醫學投資的增加也推動了醫用迴旋加速器市場的成長。政府的支持性政策，例如癌症診斷資金和醫療創新領域的公私合營，也發揮了作用。此外，同位素生產的分散化以及診斷中心的增加也推動了對小型醫院用迴旋加速器的需求。

美國食品藥物管理局 (FDA)核准使用小型迴旋加速器系統在醫院內生產鎵-68，使醫院和放射性藥物藥房能夠在現場生產高活性診斷同位素。這項進展將提高PET造影劑的可及性，減少對集中式供應鏈的依賴，並凸顯美國放射性藥物生產日益分散化的趨勢。例如，2025年4月，Telix ARTMS公司宣布，其首個使用QUANTM輻照系統迴旋加速器技術生產鎵-68並參考藥物主文件 (DMF) 的產品Gozellix已獲得美國食品藥物管理局(FDA) 的核准。此次核准將使放射性藥物藥房和醫院能夠利用ARTMS的QIS迴旋加速器技術和相關靶材，產生數居里級的鎵-68，用於Gozellix的生產。

醫用迴旋加速器市場趨勢：

癌症和慢性病發生率增加

推動市場發展的關鍵趨勢之一是全球癌症和其他慢性疾病發生率的上升。癌症仍然是全球主要死因之一，因此先進的診斷工具對於早期發現和治療至關重要。 2022年，全球有970萬人死於癌症，5,350萬人被診斷出罹患癌症。醫用迴旋加速器在生產用於PET掃描的放射性同位素方面發揮關鍵作用，而PET掃描能夠有效地早期發現各種類型的癌症。此外，心血管疾病（CVD）和神經系統疾病等慢性疾病的日益普遍也推動了對精準影像技術的需求。隨著醫療保健系統將早期診斷和有效的治療方案製定放在首位，對可靠、高品質放射性同位素的需求不斷成長，這進一步促進了醫用迴旋加速器市場的成長。

放射性藥物的進展

基於醫用迴旋加速器市場的展望，放射性藥物在核醫的診斷和治療中發揮著至關重要的作用。近年來，放射性藥物技術的進步推動了更精準、更具標靶性的放射性藥物的研發，提高了影像和治療的準確性和有效性。放射性藥物的創新拓展了其應用範圍，使其能夠用於診斷和治療更多疾病，不僅包括循環系統，還包括心臟病和神經病學。根據IMARC Group的報告顯示，2024年全球放射性藥物市場規模達58億美元，預計2033年將達到89億美元，2025年至2033年的複合年成長率（CAGR）為4.9%。此外，人工智慧（AI）和機器學習（ML）在放射性藥物研究中的應用，正在加速新型化合物的開發，並改善患者的治療效果。這些進步需要生產新的放射性同位素，這進一步擴大了醫用迴旋加速器市場的規模。

擴大醫療基礎設施和增加對診斷影像技術的投資

根據對醫用迴旋加速器市場的預測，醫療基礎設施的擴張是市場成長的主要動力。例如，截至2023年3月，印度共有169,615個服務於城鄉都市區的醫療衛生次級中心（SC）、31,882個基層醫療中心（PHC）、6,359個社區健康中心（CHC）、1,340家分區/地區醫院（SDH）、714家社區健康中心（DH）、1,340個分區/地區醫院（SDH）、714家地區醫院（DH）以及36236個都市區。公立和私立機構都在大力投資建造配備創新診斷影像技術的先進醫療設施。醫院和診斷診所中PET和PET-CT中心的增加正在推動市場成長。此外，政府為支持核醫和診斷影像所採取的積極措施和提供的資金也進一步促進了市場成長。例如，許多國家正在實施相關政策，以改善先進診斷設備的取得途徑和基本放射性藥物的供應。這些因素對醫用迴旋加速器市場的前景產生了積極影響，因為它們在生產這些先進成像程序所需的放射性同位素方面發揮著至關重要的作用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球醫用迴旋加速器市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 環形迴旋加速器
  • 方位角變化磁場（AVF）迴旋加速器

第7章 市場區隔：依產品類型分類

  • 10-12 MeV 迴旋加速器
  • 16-18 MeV 迴旋加速器
  • 19-24 MeV 迴旋加速器
  • 功率為 24 MeV 或更高的迴旋加速器

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷中心
  • 研究和學術機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Advanced Cyclotron Systems Inc.
    • Alcen
    • Best Medical International Inc.
    • General Electric Company
    • IBA RadioPharma Solutions
    • Ionetix Corporation
    • Isosolution Inc.
    • Siemens AG
    • Sumitomo Heavy Industries Ltd.
    • Varian Medical Systems Inc.
Product Code: SR112026A4573

The global medical cyclotron market size was valued at USD 265.4 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 493.8 Million by 2034, exhibiting a CAGR of 6.93% during 2026-2034. Asia Pacific dominated the market in 2025. The increasing cancer prevalence, advancements in radiopharmaceuticals, rising demand for positron emission tomography (PET) scans, technological innovations, expanding healthcare infrastructure, growing research activities, and supportive government initiatives promoting nuclear medicine and diagnostic imaging are some of the key factors contributing to the medical cyclotron market share.

The market is growing steadily due to several key factors. One major driver is the increasing demand for diagnostic imaging procedures, particularly Positron Emission Tomography (PET) scans, which require radioisotopes produced by cyclotrons. The rising global incidence of cancer and cardiovascular diseases has further amplified the need for early and accurate diagnostic tools. Technological advancements in radiopharmaceuticals and imaging techniques have improved the efficiency and precision of diagnosis, encouraging greater adoption of cyclotron systems. Additionally, expanding healthcare infrastructure in emerging economies and rising investments in nuclear medicine support medical cyclotron market growth. Supportive government policies, including funding for cancer diagnostics and public-private partnerships in healthcare innovation, are also playing a role. Moreover, the shift toward decentralized isotope production and the increasing number of diagnostic centers have strengthened the demand for compact, hospital-based cyclotrons.

FDA certification for in-house gallium-68 production using compact cyclotron systems is enabling hospitals and radiopharmacies to locally manufacture diagnostic isotopes in high activity. This development supports wider access to PET imaging agents, reduces dependence on centralized supply, and underscores a growing move toward decentralized radiopharmaceutical manufacturing in the US market. For instance, in April 2025, Telix ARTMS, Inc. announced that Gozellix became the first product certified by the US Food and Drug Administration (FDA) to reference the drug master file (DMF) for gallium-68 production using Telix ARTMS, Inc.'s QUANTM Irradiation System cyclotron technology. With this approval, radiopharmacies and hospitals would be able to generate multi-Curies of 68Ga for use with Gozellix by utilizing ARTMS' QIS cyclotron technology and related targets.

MEDICAL CYCLOTRON MARKET TRENDS:

Rising Prevalence of Cancer and Chronic Diseases

One of the primary trends driving the market is the increasing incidence of cancer and other chronic diseases worldwide. Cancer remains one of the leading causes of death globally, necessitating advanced diagnostic tools for early detection and treatment. In 2022, there were 9.7 million deaths due to cancer, and 53.5 million people living with a cancer diagnosis. Medical cyclotrons play a crucial role in producing radioisotopes used in PET scans, which are highly effective in detecting various types of cancers at an early stage. Additionally, the escalating prevalence of chronic diseases such as cardiovascular disorders (CVD) and neurological conditions has increased the demand for precise diagnostic imaging techniques. As healthcare systems emphasize early diagnosis and effective treatment plans, the need for reliable and high-quality radioisotopes is bolstering the medical cyclotron market growth.

Advancements in Radiopharmaceuticals

Based on the medical cyclotron market outlook, Radiopharmaceuticals play a crucial role in nuclear medicine for both diagnostic and therapeutic purposes. Recent advancements have led to the development of more precise and targeted radiopharmaceuticals, enhancing the accuracy and effectiveness of diagnostic imaging and treatments. This innovation in radiopharmaceuticals has expanded their application scope, enabling the diagnosis and treatment of a broader range of diseases beyond oncology, including cardiology and neurology. As a result, in 2024, the global radiopharmaceuticals market reached USD 5.8 Billion, as per a report by the IMARC Group. The market is further projected to reach USD 8.9 Billion by 2033, growing at a CAGR of 4.9% during 2025-2033. Moreover, the integration of AI and machine learning (ML) in radiopharmaceutical research has spurred the development of new compounds, improving patient outcomes. These advancements necessitate the production of novel radioisotopes, thereby providing an impetus to the medical cyclotron market size.

Expanding Healthcare Infrastructure and Investments in Diagnostic Imaging

The medical cyclotron market forecast indicates that the expansion of healthcare infrastructure significantly contributes to the market growth. For instance, in India, there are a total of 1,69,615 Sub-Centres (SCs), 31,882 Primary Health Centres (PHCs), 6,359 Community Health Centres (CHCs), 1,340 Sub-Divisional/District Hospitals (SDHs), 714 District Hospitals (DHs), and 362 Medical Colleges (MCs) serving both rural and urban areas as of March 2023, according to the Ministry of Health and Family Welfare. Both public and private sector organizations are making huge investments in the development of cutting-edge medical facilities equipped with innovative diagnostic imaging technologies. The rising development of PET and PET-CT centers in hospitals and diagnostic clinics is helping in market growth. Additionally, positive government initiatives and funding to support nuclear medicine and diagnostic imaging are further enhancing the market growth. For example, many nations are putting in place policies that enhance access to advanced diagnostic equipment and the availability of critical radiopharmaceuticals. This is having a favorable influence on the outlook of the medical cyclotron market since they are critical in the production of radioisotopes necessary for use in such advanced imaging procedures.

MEDICAL CYCLOTRON INDUSTRY SEGMENTATION:

Analysis by Type:

  • Ring Cyclotron
  • Azimuthally Varying Field (AVF) Cyclotron

As per the medical cyclotron market research report, the ring cyclotron stood as the largest component in 2025. As per the medical cyclotron industry statistics, ring cyclotrons dominate the market due to their superior capabilities in producing high-energy radioisotopes essential for advanced diagnostic imaging techniques like PET. Their design allows for continuous and efficient acceleration of particles, resulting in higher yields of radioisotopes with greater purity and consistency. Ring cyclotrons are well-suited for large-scale production in medical facilities owing to their efficiency, which guarantees a consistent supply of essential radiopharmaceuticals. Additionally, their advanced technology supports a wider range of isotopes, catering to diverse medical applications beyond oncology, such as cardiology and neurology. The combination of high production capacity, reliability, and versatility positions ring cyclotrons as the preferred choice in the medical cyclotron market.

Analysis by Product Type :

  • Cyclotron 10-12 MeV
  • Cyclotron 16-18 MeV
  • Cyclotron 19-24 MeV
  • Cyclotron 24 MeV and Above

Cyclotron 16-18 MeV led the market in 2025. The demand for cyclotrons with 16-18 MeV energy levels is mainly driven by their optimal balance between production capacity and operational efficiency. Fluorine-18, which is essential for PET imaging, is among the many radioisotopes that can be produced by these cyclotrons. The 16-18 MeV energy range allows for efficient production of high-purity isotopes with sufficient yield to meet the demands of both large hospitals and commercial radio pharmacies. Additionally, these cyclotrons are cost-effective, offering a favorable return on investment for medical facilities. Their versatility, combined with the ability to support diverse diagnostic and therapeutic applications, makes 16-18 MeV cyclotrons the preferred choice in the industry.

Analysis by End User :

  • Hospitals
  • Diagnostic Centers
  • Research and Academic Institutes
  • Others

Hospitals led the market in 2025. Medical cyclotron market insights exhibit hospitals as the biggest end users, with their critical role in providing advanced diagnostic and therapeutic services. Medical cyclotrons in hospitals produce essential radioisotopes used in PET and SPECT imaging, which are pivotal for diagnosing and monitoring various diseases, including cancer, CVDs, and neurological disorders. The integration of cyclotrons within hospital settings ensures a timely and reliable supply of these radiopharmaceuticals, enhancing patient care and treatment outcomes. Furthermore, the growing trend of in-house production of radioisotopes allows hospitals to reduce dependence on external suppliers, lower operational costs, and improve the efficiency of their nuclear medicine departments.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, Asia Pacific accounted for the largest market share. Medical cyclotron market analysis revealed Asia Pacific as the leading region due to robust healthcare infrastructure expansion, particularly in countries like China, Japan, and India, which boosts the demand for advanced diagnostic and therapeutic technologies. Increasing government investments and favorable policies support the adoption of medical cyclotrons in healthcare facilities. Additionally, the rising prevalence of cancer and other chronic diseases in the region amplifies the need for advanced imaging and treatment solutions, further driving market growth. The presence of leading cyclotron manufacturers and growing research and development (R&D) activities in nuclear medicine also contribute to the region's dominance.

KEY REGIONAL TAKEAWAYS:

UNITED STATES MEDICAL CYCLOTRON MARKET ANALYSIS

The United States medical cyclotron market is primarily driven by the growing demand for advanced diagnostic imaging, particularly positron emission tomography (PET) scans used in oncology, cardiology, and neurology. The increasing incidence of cancer and chronic diseases has heightened the need for reliable radioisotope production, notably Fluorine-18, which is widely used in PET imaging. For instance, the National Cancer Institute estimates that there will be 2,041,910 new cases of cancer in 2025 and approximately 618,120 deaths due to cancer. With many traditional nuclear reactors being phased out or operating under strict regulations, medical cyclotrons provide a safer, decentralized alternative for isotope generation. Moreover, advancements in compact and automated cyclotron technologies have improved operational efficiency and reduced the infrastructure burden, enabling adoption even in mid-sized hospitals and diagnostic centers. The increasing demand for personalized medicine has further strengthened the role of on-site cyclotron production. Government investments, favorable reimbursement policies for PET procedures, and growing partnerships between public institutions and private firms are also propelling industry expansion. Additionally, FDA approvals for new radiopharmaceuticals and a focus on increasing domestic isotope production to reduce import reliance are expanding installations. The trend of integrating cyclotrons with radiochemistry labs for streamlined operations is also attracting attention from healthcare providers seeking to enhance service offerings and reduce lead times in isotope availability, particularly for time-sensitive radiotracers.

ASIA PACIFIC MEDICAL CYCLOTRON MARKET ANALYSIS

The Asia Pacific medical cyclotron market is expanding due to increasing government support for indigenizing isotope production and strengthening national nuclear medicine programs. Several countries in the region are enhancing regulatory frameworks and offering funding incentives to encourage hospitals and academic centers to establish cyclotron facilities. Government initiatives to strengthen diagnostic capabilities, along with rising public and private healthcare expenditure, are facilitating cyclotron installations in both urban and tier-2 cities. For instance, from 2017-18 to 2023-24, expenditure on healthcare in India increased from 1.4% to 1.9%, as per the Press Information Bureau (PIB). Additionally, efforts to integrate cyclotron technology with automated radiopharmacy units are improving workflow efficiency and compliance with international safety standards. Local manufacturing of cyclotron components and turnkey radiopharmacy solutions is also gaining traction, lowering installation and maintenance costs. Academic research on novel radiotracers for diseases prevalent in Asia is further boosting demand for dedicated cyclotron facilities tailored to regional diagnostic priorities, facilitating industry expansion.

EUROPE MEDICAL CYCLOTRON MARKET ANALYSIS

The Europe medical cyclotron market is experiencing robust growth, fueled by the rising demand for radioisotopes in PET and SPECT imaging, driven by the increasing geriatric population and the growing prevalence of cancer, cardiovascular, and neurological diseases in the region. According to reports, cancer was the second leading cause of death in the European Union in 2021, with 1.1 Million deaths, which equated to 21.6% of the total number of deaths in the region. Additionally, male mortality rates from cancer were higher at 23.8% than female mortality rates at 19.4%. A strong emphasis on early and precise diagnosis is also prompting hospitals and diagnostic centers across Europe to invest in medical cyclotrons for in-house radiotracer production. Stringent regulatory frameworks around nuclear reactors and radioactive material are further leading to a shift toward decentralized, hospital-based cyclotron installations to ensure a stable and timely isotope supply. Moreover, the European Commission's initiatives to reduce dependency on imported medical isotopes and enhance domestic production capabilities are creating significant funding opportunities and research incentives. Technological advancements in compact and energy-efficient cyclotrons have made installations more feasible in smaller clinical settings, expanding the market beyond large academic centers. Other than this, collaborations between public health bodies, research institutions, and private sector players are fostering innovation and infrastructure development.

LATIN AMERICA MEDICAL CYCLOTRON MARKET ANALYSIS

The Latin America medical cyclotron market is significantly influenced by the growing demand for advanced diagnostic imaging in oncology, neurology, and cardiology, along with increasing awareness about nuclear medicine applications. Countries such as Brazil, Mexico, and Argentina are expanding public and private healthcare investments to enhance diagnostic infrastructure, including PET-CT capabilities. According to the International Trade Administration (ITA), Brazil spends 9.47% of its GDP on healthcare, equating to USD 161 Billion and making the country the largest healthcare market in Latin America. Regional efforts to modernize healthcare systems and improve early disease detection are also supporting market growth. Besides this, strategic collaborations with international cyclotron manufacturers are helping reduce costs and improve access to training and operational support in the region, supporting industry expansion.

MIDDLE EAST AND AFRICA MEDICAL CYCLOTRON MARKET ANALYSIS

The Middle East and Africa medical cyclotron market is being increasingly propelled by rising investments in nuclear medicine infrastructure and growing demand for PET imaging in cancer diagnosis and management. Countries such as the UAE, Saudi Arabia, and South Africa are expanding advanced diagnostic services as part of broader healthcare modernization efforts. Moreover, medical tourism growth in Gulf countries and the establishment of specialized cancer treatment centers are further supporting cyclotron adoption. For instance, according to a report by the IMARC Group, the medical tourism market in Saudi Arabia reached USD 1,341.1 Million in 2024 and is expected to grow at a CAGR of 21.80% during 2025-2033. The limited availability of imported isotopes, combined with the need for timely and efficient radiotracer supply, is further driving interest in localized cyclotron facilities and propelling market growth.

COMPETITIVE LANDSCAPE:

The medical cyclotron market is experiencing growth driven by several key developments. Technological advancements have led to the creation of compact, energy-efficient cyclotrons, enhancing accessibility for healthcare facilities. Public-private partnerships and government funding are increasingly common, aiming to mitigate financial barriers and expand access to cyclotron technologies. Research and development efforts are focused on producing novel radioisotopes for diagnostic and therapeutic applications. Among these trends, government initiatives and funding stand out as prevalent practices, facilitating the establishment of cyclotron facilities and promoting nuclear medicine advancements.

The report provides a comprehensive analysis of the competitive landscape in the medical cyclotron market with detailed profiles of all major companies, including:

  • Advanced Cyclotron Systems Inc.
  • Alcen
  • Best Medical International Inc.
  • General Electric Company
  • IBA RadioPharma Solutions
  • Ionetix Corporation
  • Isosolution Inc.
  • Siemens AG
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the medical cyclotron market?

2. What is the future outlook of medical cyclotron market?

3. What are the key factors driving the medical cyclotron market?

4. Which region accounts for the largest medical cyclotron market share?

5. Which are the leading companies in the global medical cyclotron market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Cyclotron Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Ring Cyclotron
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Azimuthally Varying Field (AVF) Cyclotron
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Cyclotron 10-12 MeV
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cyclotron 16-18 MeV
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cyclotron 19-24 MeV
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cyclotron 24 MeV and Above
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Advanced Cyclotron Systems Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alcen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Best Medical International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 General Electric Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 IBA RadioPharma Solutions
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ionetix Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Isosolution Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Siemens AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sumitomo Heavy Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Varian Medical Systems Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Medical Cyclotron Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Cyclotron Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Medical Cyclotron Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Medical Cyclotron Market: Breakup by Product Type (in %), 2025
  • Figure 6: Global: Medical Cyclotron Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Medical Cyclotron Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Medical Cyclotron (Ring Cyclotron) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Medical Cyclotron (Ring Cyclotron) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Medical Cyclotron (Azimuthally Varying Field Cyclotron) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Medical Cyclotron (Azimuthally Varying Field Cyclotron) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Medical Cyclotron (Cyclotron 10-12 MeV) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Medical Cyclotron (Cyclotron 10-12 MeV) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Medical Cyclotron (Cyclotron 16-18 MeV) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Medical Cyclotron (Cyclotron 16-18 MeV) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Medical Cyclotron (Cyclotron 19-24 MeV) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Medical Cyclotron (Cyclotron 19-24 MeV) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Medical Cyclotron (Cyclotron 24 MeV and Above) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Medical Cyclotron (Cyclotron 24 MeV and Above) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Medical Cyclotron (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Medical Cyclotron (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Medical Cyclotron (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Medical Cyclotron (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Medical Cyclotron (Research and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Medical Cyclotron (Research and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Medical Cyclotron (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Medical Cyclotron (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Medical Cyclotron Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Medical Cyclotron Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Medical Cyclotron Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Medical Cyclotron Industry: SWOT Analysis
  • Figure 78: Global: Medical Cyclotron Industry: Value Chain Analysis
  • Figure 79: Global: Medical Cyclotron Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Medical Cyclotron Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Medical Cyclotron Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Medical Cyclotron Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 4: Global: Medical Cyclotron Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Medical Cyclotron Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Medical Cyclotron Market: Competitive Structure
  • Table 7: Global: Medical Cyclotron Market: Key Players